ArticleMolecular medicine (Cambridge, Mass.)2022

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma.

Ji-Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.